Japan’s Takeda Agrees To $2.4B Settlement In Diabetes Drug Actos Lawsuit Over Cancer Risk Allegations
International Business Times
April 29, 2015
[…] Japan’s Takeda Pharmaceutical Co. Ltd. reached a settlement on Tuesday on thousands of lawsuits filed against the company over its diabetes drug Actos. The firm agreed to reimburse families and patients in the United States up to $2.4 billion over allegations that the drug was linked to bladder cancer. […]